Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

NIH Grants & Funding for Autoimmune Polyendocrine Syndrome Type 1 | Kisho | Kisho

Back to Autoimmune Polyendocrine Syndrome Type 1

Autoimmune Polyendocrine Syndrome Type 1 — NIH Grants & Funding

Active and recent NIH-funded research on Autoimmune Polyendocrine Syndrome Type 1. Data from NIH RePORTER, last 36 months.

MONDO:0009411

Looking for specific grants? The Recent Research tab lets you search and filter by topic.

Funding Landscape

Autoimmune Polyendocrine Syndrome Type 1 has active NIH research funding with 6 funded grants totaling $3.7M.

6funded grants from NIH

Portfolio: $1.8MCumulative: $3.7M3 active3 completed6 PIs4 institutions

By Research Theme

Basic Science

Funding by Fiscal Year

NIH fiscal year (Oct–Sep)

$1.2M

FY22

$638K

FY23

$1.1M

FY24

$828K

FY25

By Funding Mechanism

F31

R01

R21

R37

ZIA

Funding Gap Analysis

Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Autoimmune Polyendocrine Syndrome Type 1. Strongest funded area: Basic Science.

Clinical ResearchTrials Active, No NIH Grants

2 clinical trials registered but no NIH-funded clinical or translational research grants found for autoimmune polyendocrine syndrome type 1. Trials may be industry-sponsored or funded through non-NIH sources.

Adjacent Research(4 grants)

These grants mention Autoimmune Polyendocrine Syndrome Type 1 as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.

Other(4)

OtherZIACompleted

Studies of Inherited Causes of Fungal Susceptability

Rosenzweig, Sergio·NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

$3,597,410 (FY2025)

NIH RePORTER

OtherZIACompleted

Studies of human microbes and potential perturbations

Kong, Heidi·NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES

$1,086,911 (FY2025)

NIH RePORTER

OtherZIACompleted

Role of IKK alpha in lymphoid organ development

Hu, Yinling·DIVISION OF BASIC SCIENCES - NCI

$799,698 (FY2025)

NIH RePORTER

OtherK08Completed

Unraveling the Molecular Function of Mosaic, a gene mediating immune dysregulation

CHAN, ALICE·UNIVERSITY OF CALIFORNIA, SAN FRANCISCO·SAN FRANCISCO, CA

$205,684 (FY2023)

NIH RePORTER

Kisho

Autoimmune Polyendocrine Syndrome Type 1 — NIH Grants & Funding

Funding Landscape

By Research Theme

Funding by Fiscal Year

By Funding Mechanism

Funding Gap Analysis

Adjacent Research(4 grants)

Other(4)

Studies of Inherited Causes of Fungal Susceptability

Studies of human microbes and potential perturbations

Role of IKK alpha in lymphoid organ development

Unraveling the Molecular Function of Mosaic, a gene mediating immune dysregulation

Top Funded Institutions

Top Principal Investigators